Our previous research showed that exogenous injection of TSG-6 can effectively relieve intestinal inflammation and elevate the goblet cell count in mice with colitis (Yang et al. 2021), yet its precise impact on epithelial barrier restoration remains unclear. This evidence concerns the gene TNFAIP6 and colitis.